A phase II, open label, randomized controlled trial of nivolumab plus ipilimumab with stereotactic radiotherapy versus ipilimumab plus nivolumab alone in patients with melanoma brain metastases (ABC -X Trial).

被引:11
作者
Gonzalez, Maria
Hong, Angela M.
Carlino, Matteo S.
Atkinson, Victoria
Wang, Wei
Lo, Serigne
Brown, Michael Paul
Foote, Matthew C.
Pinkham, Mark B.
Le, Hien
Roos, Daniel E.
Osorio, Monica
Haghighi, Neda
Kok, David
Postow, Michael A.
McArthur, Grant A.
Menzies, Alexander M.
Long, Georgina V.
机构
[1] Melanoma Inst Australia, Sydney, NSW, Australia
[2] Univ Sydney, Chris OBrien Lifehouse, Melanoma Inst Australia, Sydney, NSW, Australia
[3] Univ Sydney, Westmead Hosp, Sydney, NSW, Australia
[4] Univ Sydney, Blacktown Hosp, Melanoma Inst Australia, Sydney, NSW, Australia
[5] Univ Queensland, Gallipoli Med Res Fdn, Princess Alexandra Hosp, Woolloongabba, Qld, Australia
[6] Westmead Hosp, Crown Princess Mary Canc Ctr, Sydney, NSW, Australia
[7] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia
[8] Royal Adelaide Hosp, Adelaide, SA, Australia
[9] Univ Queensland, Princess Alexandra Hosp, Brisbane, Qld, Australia
[10] Univ Queensland, Queensland Univ Technol, Gamma Knife Ctr Queensland, Princess Alexandra Hosp, Woolloongabba, Qld, Australia
[11] Univ Adelaide, Royal Adelaide Hosp, Adelaide, SA, Australia
[12] Melanoma Inst Australia, Sydney, NSW, Australia
[13] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[14] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[15] Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[16] Univ Sydney, Melanoma Inst Australia, Royal North Shore Hosp, Sydney, NSW, Australia
[17] Royal North Shore Hosp, Sydney, NSW, Australia
[18] Mater Hosp, Sydney, NSW, Australia
关键词
D O I
10.1200/JCO.2019.37.15_suppl.TPS9600
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS9600
引用
收藏
页数:2
相关论文
empty
未找到相关数据